These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 28068175)
1. CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study. Qiu J; Peng B; Tang Y; Qian Y; Guo P; Li M; Luo J; Chen B; Tang H; Lu C; Cai M; Ke Z; He W; Zheng Y; Xie D; Li B; Yuan Y J Clin Oncol; 2017 Mar; 35(7):734-742. PubMed ID: 28068175 [TBL] [Abstract][Full Text] [Related]
2. A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma. Tian XP; Su N; Wang L; Huang WJ; Liu YH; Zhang X; Huang HQ; Lin TY; Ma SY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sun C; Sang W; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Pan XY; Hai L; Li GW; Song LY; Kang TB; Xie D; Cai QQ Clin Cancer Res; 2020 Jul; 26(14):3760-3770. PubMed ID: 32234760 [TBL] [Abstract][Full Text] [Related]
3. Genes associated with recurrence of hepatocellular carcinoma: integrated analysis by gene expression and methylation profiling. Yang JD; Seol SY; Leem SH; Kim YH; Sun Z; Lee JS; Thorgeirsson SS; Chu IS; Roberts LR; Kang KJ J Korean Med Sci; 2011 Nov; 26(11):1428-38. PubMed ID: 22065898 [TBL] [Abstract][Full Text] [Related]
4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
5. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma. Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma. Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816 [TBL] [Abstract][Full Text] [Related]
9. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Roessler S; Jia HL; Budhu A; Forgues M; Ye QH; Lee JS; Thorgeirsson SS; Sun Z; Tang ZY; Qin LX; Wang XW Cancer Res; 2010 Dec; 70(24):10202-12. PubMed ID: 21159642 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma. Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer. Peng Y; Shui L; Xie J; Liu S J Cell Mol Med; 2020 Aug; 24(16):9378-9387. PubMed ID: 32649035 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma. Nishida N; Nishimura T; Nakai T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Kudo M Dig Dis; 2014; 32(6):658-63. PubMed ID: 25376281 [TBL] [Abstract][Full Text] [Related]
13. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients. Bedon L; Dal Bo M; Mossenta M; Busato D; Toffoli G; Polano M Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499054 [TBL] [Abstract][Full Text] [Related]
14. CpG methylation signature predicts prognosis in breast cancer. Du T; Liu B; Wang Z; Wan X; Wu Y Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283 [TBL] [Abstract][Full Text] [Related]
15. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645 [TBL] [Abstract][Full Text] [Related]
16. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study. Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556 [TBL] [Abstract][Full Text] [Related]
18. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection. Liu WR; Tian MX; Tang Z; Fang Y; Zhou YF; Song SS; Jiang XF; Wang H; Tao CY; Zhou PY; Qu WF; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH Br J Cancer; 2020 Jul; 123(1):92-100. PubMed ID: 32376890 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas. Cui C; Lu Z; Yang L; Gao Y; Liu W; Gu L; Yang C; Wilson J; Zhang Z; Xing B; Deng D; Sun ZS Mol Carcinog; 2016 Jul; 55(7):1163-74. PubMed ID: 26138747 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue. Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]